Thus, it is reasonable that GL-1196 suppressed the PAK4/c-Src/EGFR/cyclinD1 pathway and CDK4/6 expression, which, in turn, inhibited the transition of cells from G1 to S phase, and finally resulted in the anti-proliferative effect on gastric cancer cells. Here, CDK4 is linked to gastric cancer.